iRhythm Stock (NASDAQ:IRTC)
Previous Close
$119.64
52W Range
$92.52 - $212.00
50D Avg
$153.90
200D Avg
$161.70
Market Cap
$3.71B
Avg Vol (3M)
$663.71K
Beta
1.15
Div Yield
-
IRTC Company Profile
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
IRTC Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Non-contracted Third-party Payors | $49.94M | $42.73M | $32.07M |
| Centers For Medicare And Medicaid | $179.35M | $142.39M | $122.41M |
| Commercial Payors | $392.23M | $311.61M | $267.19M |
| Healthcare Institutions | $125.61M | $95.11M | $71.00M |
Fiscal year ends in Dec 25 | Currency in USD